DTWD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.011390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.236800E-01
Normal-vs-Stage2
9.188300E-02
Normal-vs-Stage3
4.095900E-03
Normal-vs-Stage4
6.628000E-01
Stage1-vs-Stage2
1.749030E-01
Stage1-vs-Stage3
6.293800E-02
Stage1-vs-Stage4
9.772600E-01
Stage2-vs-Stage3
1.480220E-01
Stage2-vs-Stage4
2.429600E-01
Stage3-vs-Stage4
1.454010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.514000E-02
Normal-vs-AfricanAmerican
4.734800E-01
Normal-vs-Asian
1.084380E-01
Caucasian-vs-AfricanAmerican
3.226800E-01
Caucasian-vs-Asian
5.524000E-01
AfricanAmerican-vs-Asian
3.242600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.319380E-01
Normal-vs-Female
7.944000E-02
Male-vs-Female
6.941400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.685800E-02
Normal-vs-Age(41-60Yrs)
2.103800E-01
Normal-vs-Age(61-80Yrs)
6.130400E-02
Normal-vs-Age(81-100Yrs)
2.673200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.148600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.704400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.066800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.047700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.360600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.732200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.818000E-02
Normal-vs-Daily Drinker
1.803960E-02
Normal-vs-Weekly Drinker
9.497600E-02
Normal-vs-Occasional Drinker
1.755040E-01
Normal-vs-Social Drinker
4.139600E-01
Non Drinker-vs-Daily Drinker
1.332370E-01
Non Drinker-vs-Weekly Drinker
7.131000E-01
Non Drinker-vs-Occasional Drinker
6.674200E-01
Non Drinker-vs-Social Drinker
2.981400E-01
Daily Drinker-vs-Weekly Drinker
4.068400E-01
Daily Drinker-vs-Occasional Drinker
1.055410E-01
Daily Drinker-vs-Social Drinker
4.926100E-02
Weekly Drinker-vs-Occasional Drinker
5.271400E-01
Weekly Drinker-vs-Social Drinker
2.993000E-01
Occasional Drinker-vs-Social Drinker
5.815600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.806400E-02
Normal-vs-Grade 2
7.978300E-03
Normal-vs-Grade 3
3.145700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.970000E-01
Grade 1-vs-Grade 3
3.294800E-01
Grade 1-vs-Grade 4
5.806400E-02
Grade 2-vs-Grade 3
3.347800E-01
Grade 2-vs-Grade 4
7.978300E-03
Grade 3-vs-Grade 4
3.145700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.062440E-01
Normal-vs-NonDiabetic
5.413900E-02
Diabetic-vs-NonDiabetic
7.701000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.298200E-02
Normal-vs-NoPancreatitis
7.980100E-02
Pancreatitis-vs-NoPancreatitis
4.858200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.547800E-01
Normal-vs-N1
6.014300E-02
N0-vs-N1
5.293200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.368800E-01
Normal-vs-TP53-NonMutant
3.304000E-01
TP53-Mutant-vs-TP53-NonMutant
3.698800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
